We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+14.09%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$79.1B
AUM Growth
+$7.99B
(+11%)
Cap. Flow
-$5.86B
Cap. Flow
% of AUM
-7.4%
Top 10 Holdings %
Top 10 Hldgs %
22.63%
Holding
2,061
New
445
Increased
504
Reduced
465
Closed
231
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sysco
SYY
|
+$273M |
| 2 |
Waste Management
WM
|
+$168M |
| 3 |
Lowe's Companies
LOW
|
+$160M |
| 4 |
PNC Financial Services
PNC
|
+$154M |
| 5 |
Unilever
UL
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$548M |
| 2 |
Apple
AAPL
|
+$372M |
| 3 |
CSX Corp
CSX
|
+$369M |
| 4 |
Infosys
INFY
|
+$238M |
| 5 |
Kimberly-Clark
KMB
|
+$235M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.16% |
| 2 | Healthcare | 14.65% |
| 3 | Financials | 13.08% |
| 4 | Industrials | 9.66% |
| 5 | Consumer Discretionary | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Lumentum
LITE
$69.7B
| $3.22M | ﹤0.01% |
+34,011
| New | +$2.93M |
|
577
Factset
FDS
$10.1B
| $3.19M | ﹤0.01% |
9,587
-6,983
| -42% | -$2.31M |
|
578
National Vision
EYE
$1.8B
| $3.13M | ﹤0.01% |
+69,192
| New | +$3.01M |
|
579
Ambev
ABEV
$46.7B
| $3.08M | ﹤0.01% |
1,005,326
-12,363
| -1% | -$33.3K |
|
580
iShares Core MSCI EAFE ETF
IEFA
$195B
| $3.07M | ﹤0.01% |
44,466
-4,216
| -9% | -$273K |
|
|
EMF
581
Templeton Emerging Markets Fund
EMF
$325M
| $3.06M | ﹤0.01% |
163,269
-256,618
| -61% | -$4.34M |
|
582
Capital One
COF
$133B
| $3.05M | ﹤0.01% |
30,874
+23,118
| +298% | +$1.97M |
|
583
Simpson Manufacturing
SSD
$8.05B
| $3.03M | ﹤0.01% |
32,464
-3,000
| -8% | -$279K |
|
584
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.58B
| – | – |
0
| – | – |
|
585
Rapid7
RPD
$717M
| $3M | ﹤0.01% |
+33,330
| New | +$2.38M |
|
586
Cytokinetics
CYTK
$10.4B
| $2.98M | ﹤0.01% |
143,399
-118,115
| -45% | -$2.16M |
|
587
MSCI
MSCI
$41B
| $2.96M | ﹤0.01% |
6,636
-394
| -6% | -$155K |
|
588
First Trust NASDAQ Cybersecurity ETF
CIBR
$15.3B
| $2.94M | ﹤0.01% |
66,221
+60,182
| +997% | +$2.3M |
|
589
Cintas
CTAS
$81.2B
| $2.91M | ﹤0.01% |
32,932
+28,180
| +593% | +$2.45M |
|
590
Vanguard Short-Term Bond ETF
BSV
$44.6B
| – | – |
0
| – | – |
|
591
Portland General Electric
POR
$5.78B
| $2.87M | ﹤0.01% |
67,110
-31,066
| -32% | -$1.27M |
|
592
Ameriprise Financial
AMP
$48.8B
| $2.86M | ﹤0.01% |
14,726
-1,209
| -8% | -$216K |
|
593
iShares Core S&P Total US Stock Market ETF
ITOT
$97.8B
| $2.83M | ﹤0.01% |
32,865
| – | – |
|
|
TWOU
594
DELISTED
2U Inc
TWOU
| $2.81M | ﹤0.01% |
+2,339
| New | +$2.51M |
|
595
Stride
LRN
$3.37B
| $2.8M | ﹤0.01% |
+131,792
| New | +$3.27M |
|
596
Reliance Steel & Aluminium
RS
$21.6B
| $2.79M | ﹤0.01% |
23,308
| – | – |
|
597
Primoris Services
PRIM
$4.46B
| $2.77M | ﹤0.01% |
100,378
| – | – |
|
598
Invitation Homes
INVH
$18.1B
| $2.76M | ﹤0.01% |
92,899
-43,469
| -32% | -$1.25M |
|
599
iShares Core Dividend Growth ETF
DGRO
$43.5B
| $2.69M | ﹤0.01% |
59,915
| – | – |
|
600
Franklin FTSE Japan ETF
FLJP
$4.07B
| $2.68M | ﹤0.01% |
90,085
| – | – |
|
Similar funds
QCM
Lazard Asset Management's Q4 2020 Portfolio in Review
As of Q4 2020, Lazard Asset Management held 2,061 positions worth $79.1B, up 11% from $71.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $5.86B in Q4 2020, closing 231 positions and reducing 465 holdings. Its most notable exit was Unilever NV New York Registry Shares, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Sotera Health worth $100M.
- Lazard Asset Management's largest Q4 2020 buy was Sotera Health: 3,651,831 shares worth $100M.
- Lazard Asset Management added most to Sysco in Q4 2020, an estimated $273M increase.
- Lazard Asset Management's biggest Q4 2020 reduction was Pfizer, cutting an estimated $548M.
- Lazard Asset Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $112M.
- Lazard Asset Management's ten largest holdings make up 23% of its $79.1B portfolio in Q4 2020.
- Lazard Asset Management opened 445 new positions and closed 231 in Q4 2020.
- Lazard Asset Management's portfolio value rose 11% quarter-over-quarter to $79.1B.
Based on Lazard Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.